HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)
9.955USD+0.86%Mkt Cap: 43.41B $P/E: 20.14

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the As…

HeadlineSourceTime
Older
Procter & Gamble to acquire Thorne for $3.8 billion, CEO says

Investing.com -- Procter & Gamble Co. reached an agreement to acquire supplement maker Thorne for $3.8 billion, with the deal set to be announced later today.

Investing.com
ACCO vs. HLN: Which Stock Is the Better Value Option?

ACCO vs. HLN: Which Stock Is the Better Value Option?

Zacks
Haleon PLC (HLN) (H1 2026) Earnings Call Highlights: Organic Growth Improves, North America ...

Haleon PLC (HLN) delivers sequential organic sales growth of 3.1% in Q2, with strong North America and emerging market performance offsetting persistent respiratory weakness.

GuruFocus.com
Sensodyne maker Haleon slips as sales growth concerns overshadow profit beat

July 30 (Reuters) - Sluggish European demand and weak respiratory sales raised doubts on Thursday about whether Haleon can ‌meet its sales targets, sending shares in the consumer health company lower despite ‌better-than-expected first-half profit. The British maker of Theraflu and Flonase cold medicines and Sensodyne toothpaste reported first-half organic ​revenue growth of 2.

Reuters
Haleon H1 Earnings Call Highlights

Haleon (NYSE:HLN) said its second-quarter organic sales growth accelerated to 3.1% from 2.2% in the first quarter, supported by improved execution in North America, continued growth in emerging markets and a stronger contribution from pain relief and oral health products. Chief Executive Officer Br

MarketBeat
Haleon slides as quality of growth questioned

Haleon PLC (LSE:HLN, NYSE:HLN) shares fell 2.9% to 368.7p after the consumer healthcare group reported improving second-quarter sales but left its full-year guidance unchanged. Organic revenue increased 3.1% in the second quarter, split between 1.7% from pricing and 1.4% from volumes and...

Proactive
Is Kenvue Stock Attractive After Margin Gains and Deal Uncertainty

KVUE's margin gains and stronger cash flow boost its appeal, but slow organic growth, debt and deal uncertainty keep the outlook balanced.

Zacks
Kenvue Benefits From Consumer Health Trends and Margin Expansion

Kenvue's beauty momentum, margin expansion and stronger cash flow support its outlook as uneven demand and deal uncertainty temper visibility.

Zacks
Haleon (HLN) Partners with Microsoft (MSFT) to Advance Digital and AI Capabilities

Haleon (NYSE:HLN) is one of the best up and coming stocks to invest in right now. On June 1, Haleon announced a five-year collaboration with Microsoft (NASDAQ:MSFT) to scale its digital, data, and AI capabilities. This partnership aims to accelerate the company’s global “Win as One” strategy by integrating Microsoft’s cloud and AI tools into […]

IInsider Monkey
Haleon Signs a Five-Year Agreement With Microsoft (MSFT) to Deploy Agentic AI Across Its Global Operations

Microsoft Corporation (NASDAQ:MSFT) is one of the top stocks to buy according to Whale Rock Capital Management. On June 29, Haleon, a consumer health company, announced a new five-year collaboration with Microsoft Corporation (NASDAQ:MSFT) to expand the use of cloud, data, and artificial intelligence tools across Haleon’s global operations. Haleon said the deal builds on […]

IInsider Monkey